HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology145 papers

Fibrosarcoma

Last edited: 4/15/2026

Overview

Fibrosarcoma is a malignant mesenchymal tumor characterized by the proliferation of fibroblastic cells, rarely occurring in uncommon sites such as the skull 1.

Diagnosis

  • Imaging (CT, MRI) essential for initial assessment and localization 1.
  • Histopathological examination required for definitive diagnosis, showing malignant fibroblastic proliferation 1.
  • Immunohistochemistry may aid in distinguishing from other spindle cell tumors 1.
  • Grading based on mitotic activity and tumor cellularity, typically using FNCLCC (FNCLCC grading system) 1.

    • Management

  • Surgical resection with clear margins is the primary treatment modality 1.
  • Adjuvant radiotherapy often recommended for high-grade tumors or incomplete resection 1.
  • Chemotherapy may be considered for advanced or metastatic disease, though specific regimens are not detailed in the abstract 1.

    • Special Populations

  • No specific data provided regarding pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.

    • Key Recommendations

  • Primary treatment for fibrosarcoma of the skull should involve complete surgical resection with negative margins 1 (Evidence: Expert opinion).
  • Histopathological confirmation is critical for diagnosis, utilizing imaging studies for initial evaluation 1 (Evidence: Expert opinion).
  • Consider adjuvant radiotherapy for high-grade fibrosarcoma or cases with incomplete surgical margins 1 (Evidence: Expert opinion).

    • References

    1 Mansfield JB. Primary fibrosarcoma of the skull. Case report. Journal of neurosurgery 1977. link

    Original source

    1. [1]
      Primary fibrosarcoma of the skull. Case report. — Mansfield JB Journal of neurosurgery (1977)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG